Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years

Duo Yun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7999-5626; OpenAlex author ID A5085608874. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Letter to the editor regarding "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and bor… Co-author DOI 10.1016/j.surg.2024.09.012↗
  2. Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. First author DOI 10.1038/s41420-024-01890-y↗
  3. An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer. Co-author DOI 10.3389/fcell.2022.975684↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hai Yang · 2 shared papers, 2022–2024 · strength 0.31
  2. Nathalie Britzen‐Laurent · 2 shared papers, 2022–2024 · strength 0.31
  3. Robert Grützmann · 2 shared papers, 2022–2024 · strength 0.31
  4. Christian P. Pilarsky · 2 shared papers, 2022–2024 · strength 0.31
  5. Yanxi Lu · 1 shared paper, 2024 · strength 0.15
  6. Jinping Zhang · 1 shared paper, 2024 · strength 0.15
  7. Bin Lan · 1 shared paper, 2024 · strength 0.15
  8. Eva Lentsch · 1 shared paper, 2024 · strength 0.15
  9. Hang He · 1 shared paper, 2024 · strength 0.15
  10. Marc P. Stemmler · 1 shared paper, 2024 · strength 0.15
  11. Shuman Zhang · 1 shared paper, 2024 · strength 0.15
  12. Hao Yang · 1 shared paper, 2024 · strength 0.15
  13. Debabrata Mukhopadhyay · 1 shared paper, 2024 · strength 0.15
  14. Andrew Victor Biankin · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.